Government vows to investigate potential harmful substances

Published: 2004-08-10 06:57:00

Updated: 2004-08-10 06:57:00

Amid mounting public outcry over the belated ban of the Korea Food and Drug Administration on phenylpropanolamine (PPA)-containing cold remedies, the government unveiled its plan to make efforts to remove PPA-containing products from the market by October, and set up an independency agency to gat...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK